PExA AB announces that it has received an order from the German Federal Institute for Occupational Safety and Health (BAuA) for a second PExA instrument. The system will be used in ongoing research focusing on airborne particles and respiratory infections. BAuA has been a user of PExA technology for several years, and this follow-on order…
Read morePExA announces that the Company’s instrument and method are playing an increasingly clear role in the growing research environment at Örebro University and Region Örebro County, focused on occupational particle exposure and early biomarkers of lung effects. Örebro University and Region Örebro County have been awarded SEK 2.4 million from Nyckelfonden 2026 for the RESPIMARK…
Read moreAt Life Science Day in Gothenburg on March 4, Tomas Gustafsson, CEO of PExA AB, presented the company’s technology for collecting biological material from the small airways through analysis of particles in exhaled air. A recording of the presentation is now available online. PExA’s instrument enables non-invasive sampling from the smallest airways of the lung—an area where…
Read morePExA AB has received an order for a research instrument from the Norwegian National Institute of Occupational Health (STAMI) for studying respiratory diseases through analysis of exhaled particles. Delivery is expected during the first half of 2026. The instrument will initially be used in a research study focusing on occupational exposure and biological effects in…
Read moreProfessor Anna-Carin Olin, founder of PExA and Professor of Occupational and Environmental Medicine at the University of Gothenburg, has been interviewed in the Swedish newspaper Göteborgs-Posten about how lung diseases may develop in the small airways long before they can be detected using current methods. “In Sweden, approximately 15 percent of all people who develop…
Read more
